Butive 5mg
Butive 5mg. Tablets USP
Composition
Each tablet contains:
Oxybutynin Hydrochloride USP…5 mg
Excipients………q.s.
THERAPEUTIC INDICATIONS
Butive® (Oxybutynin) is indicated for the symptomatic treatment of urgent urinary incontinence and/or increased urinary frequency as may occur in patients with unstable bladder.
DOSAGE
Adults: 5 mg 3 times/daily. In the case of nighttime voiding disorder: 15 mg/daily in one single intake by the end of the day.
PRESENTATIONS
Carton containing 30 tablets in blister pack plus leaflet.